Please select the option that best describes you:

Would you do SRS for a patient who cannot receive gadolinium contrast and has a single brain metastasis on non-contrast MRI?  

For patients with eGFR of < 30, there is a risk of irreversible nephrogenic systemic fibrosis with gadolinium. Would you prefer whole brain for these patients or SRS for the lesion noted on non-contrast MRI?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Mount Sinai Medical Center Miami
Risk of NSF is quite small, and depending on the c...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more